The Corporate Ozempic Problem: business leaders treating AI as a cost-cutting tool rather than rocket fuel for future work transformation

The Corporate Ozempic Problem occurs when business leaders treat generative AI as a cost-cutting tool rather than rocket fuel for future work transformation — shrinking their operations when they should be using AI to accelerate and expand what's possible.